Furthermore, Aβ pathology has been associated with increased plasma pTau levels only in individuals positive for astrocyte reactivity (i.e., elevated GFAP), suggesting a modulating role of astrocytic activity between Aβ and tau pathology in AD (63). This evidence concerns the gene MAPT and Alzheimer disease.